Brief: Aligos Therapeutics Strengthens Senior Leadership Team With The Appointment Of Hardean Achneck, MD As Chief Medical Officer
24/09/2024 13:44
Sept 24 (Reuters) - Aligos Therapeutics Inc ALGS.O :
* ALIGOS THERAPEUTICS STRENGTHENS SENIOR LEADERSHIP TEAM
WITH THE
APPOINTMENT OF HARDEAN ACHNECK, MD AS CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nGNX7qCLwZ
Further company coverage: ALGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pliant Therapeutics
See all newsBrief: Pliant Therapeutics Announces Presentations At The 2026 Annual Meeting
Brief: Pliant Therapeutics Appoints David Raben, M.D., As Chief Medical Officer
RCS - Redx Pharma Limited - Redx Announces Final Audited Results
RCS - Redx Pharma Limited - Close of Series A; Strengthened Board Composition
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals